Author(s) :

Aneela Hussain, Ayesha Quddus, Abdul Raheem, Muhammad Zaid Khalil, Muhammad Zubair.

Volume/Issue :

Abstract :

Ebola hemorrhagic fever (EHF) is a highly infectious ailment, caused by the Ebola virus. It is a zoonotic disease that can cause mortality up to 90%. Once the Ebola virus enters the host body, it suppresses the immune system and systemic indications, that include immediate inflammatory responses and multi-organ damage. Ebola virus can be transmitted mainly by contact with body fluids, aerosols, and sexual contact. Clinical signs and symptoms include myalgia, sore throat, anorexia, tachypnoea, fatigue, skin rashes, convulsions, and coma. The definitive or natural host for the Ebola virus is still unknown that’s why it doesn’t have any definitive treatment. Supportive and symptomatic treatment such as nutritional support by antibiotics or antimalarial drugs, are the only available options to treat Ebola hemorrhagic fever.

No. of Downloads :

6